Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Desano Pharmaceuticals is a prominent Chinese pharmaceutical company specializing in the development, manufacture, and global supply of antiretroviral (ARV) drugs and active pharmaceutical ingredients (APIs). As a core subsidiary of the Acebright Group, the company has become one of the world's largest manufacturing bases for HIV/AIDS medications, holding numerous WHO prequalifications and US FDA approvals. Desano plays a critical role in global health initiatives through partnerships with the Medicines Patent Pool and international procurement agencies to provide affordable treatments for infectious diseases. Beyond its leadership in HIV, the company is expanding its portfolio into anti-malarial, anti-HBV, and oncology therapeutics, leveraging its integrated R&D and large-scale GMP manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Desano Chem.